CANADA LIFE ASSURANCE Co Boosts Holdings in Zebra Technologies Co. (NASDAQ:ZBRA)

CANADA LIFE ASSURANCE Co increased its stake in shares of Zebra Technologies Co. (NASDAQ:ZBRA) by 9.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 42,591 shares of the industrial products company’s stock after purchasing an additional 3,607 shares during the period. CANADA LIFE ASSURANCE Co owned 0.08% of Zebra Technologies worth $16,441,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ZBRA. Vanguard Group Inc. grew its holdings in shares of Zebra Technologies by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 6,260,530 shares of the industrial products company’s stock worth $2,417,942,000 after buying an additional 55,130 shares in the last quarter. Invesco Ltd. raised its holdings in Zebra Technologies by 1.5% in the 4th quarter. Invesco Ltd. now owns 1,422,986 shares of the industrial products company’s stock valued at $549,586,000 after acquiring an additional 20,992 shares during the last quarter. Geode Capital Management LLC lifted its stake in Zebra Technologies by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 1,276,198 shares of the industrial products company’s stock worth $491,935,000 after purchasing an additional 30,496 shares in the last quarter. Schroder Investment Management Group grew its position in shares of Zebra Technologies by 62.8% in the fourth quarter. Schroder Investment Management Group now owns 983,715 shares of the industrial products company’s stock valued at $379,930,000 after purchasing an additional 379,491 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of Zebra Technologies by 3.0% in the fourth quarter. JPMorgan Chase & Co. now owns 934,609 shares of the industrial products company’s stock valued at $360,965,000 after purchasing an additional 27,544 shares in the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Zebra Technologies Stock Up 0.9 %

Zebra Technologies stock opened at $226.73 on Monday. The firm has a market capitalization of $11.65 billion, a P/E ratio of 22.27 and a beta of 1.76. The stock’s fifty day simple moving average is $279.34 and its 200-day simple moving average is $351.51. Zebra Technologies Co. has a twelve month low of $205.73 and a twelve month high of $427.76. The company has a current ratio of 1.43, a quick ratio of 1.03 and a debt-to-equity ratio of 0.58.

Zebra Technologies (NASDAQ:ZBRA) last announced its quarterly earnings data on Thursday, February 13th. The industrial products company reported $3.62 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.85 by ($0.23). Zebra Technologies had a net margin of 10.60% and a return on equity of 18.34%. The company had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.31 billion. As a group, equities analysts expect that Zebra Technologies Co. will post 13.71 earnings per share for the current fiscal year.

Insider Buying and Selling at Zebra Technologies

In other Zebra Technologies news, Director Anders Gustafsson bought 500 shares of the company’s stock in a transaction that occurred on Monday, February 24th. The shares were purchased at an average price of $311.00 per share, with a total value of $155,500.00. Following the completion of the acquisition, the director now directly owns 202,176 shares of the company’s stock, valued at $62,876,736. This represents a 0.25 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.84% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Barclays lowered their price objective on Zebra Technologies from $407.00 to $326.00 and set an “equal weight” rating on the stock in a research note on Friday, February 14th. Morgan Stanley lowered their price target on shares of Zebra Technologies from $390.00 to $232.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 8th. Truist Financial cut their price objective on shares of Zebra Technologies from $379.00 to $254.00 and set a “hold” rating for the company in a research report on Tuesday, April 8th. UBS Group decreased their target price on shares of Zebra Technologies from $445.00 to $425.00 and set a “buy” rating on the stock in a report on Tuesday, February 18th. Finally, Needham & Company LLC cut their price target on shares of Zebra Technologies from $430.00 to $395.00 and set a “buy” rating for the company in a report on Friday, February 14th. Five equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $343.36.

Zebra Technologies Company Profile

Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide. It operates in two segments, Asset Intelligence & Tracking, and Enterprise Visibility & Mobility. The company designs, manufactures, and sells printers that produce labels, wristbands, tickets, receipts, and plastic cards; dye-sublimination thermal card printers that produce images, which are used for personal identification, access control, and financial transactions; radio frequency identification device (RFID) printers that encode data into passive RFID transponders; accessories and options for printers, including carrying cases, vehicle mounts, and battery chargers; stock and customized thermal labels, receipts, ribbons, plastic cards, and RFID tags for printers; and temperature-monitoring labels primarily used in vaccine distribution.